D
David P. Slovut
Researcher at Icahn School of Medicine at Mount Sinai
Publications - 7
Citations - 1256
David P. Slovut is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Fibromuscular dysplasia & Renal artery. The author has an hindex of 4, co-authored 6 publications receiving 1199 citations.
Papers
More filters
Journal ArticleDOI
Fibromuscular dysplasia
David P. Slovut,Jeffrey W. Olin +1 more
TL;DR: The most common clinical manifestations of fibromuscular dysplasia (FMD) are hypertension due to renal artery involvement and transient ischemic attack or stroke due to carotid or vertebral artery involvement.
Journal ArticleDOI
Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial
Deepak L. Bhatt,Muthiah Vaduganathan,David E. Kandzari,Martin B. Leon,Krishna J. Rocha-Singh,Raymond R. Townsend,Barry T. Katzen,Suzanne Oparil,Sandeep S. Brar,Vanessa DeBruin,Martin Fahy,George L. Bakris,Sidney Cohen,Ralph A D'Agostino,Murray D. Esler,John M. Flack,B.B. Katzen,Laura Mauri,Manuela Negoita,Ziad A. Abbud,Tayo Addo,David E. Anderson,John S. Angle,Herbert D. Aronow,Anvar Babaev,Keith H. Benzuly,Somjot S Brar,David Brown,D Calhoun,P A Casale,Sheldon Chaffer,James W. Choi,Eugene Chung,Debbie L. Cohen,Mark A. Creager,George Dangas,Harold L. Dauerman,Shukri David,Mark Davies,Eduardo de Marchena,Ali E. Denktas,Chandan Devireddy,William E. Downey,Mark E. Dunlap,D. Charles Fisher,Magdi Ghali,Eric Gnall,Raghava R. Gollapudi,Mark Goodwin,Nilesh J. Goswami,Luis Gruberg,Rajiv Gulati,Anuj Gupta,Anjan Gupta,Hitinder S. Gurm,Jeffrey W. Hastings,Scott Kinlay,Robert Kipperman,Maurice Buchbinder,Ajay J. Kirtane,Richard Kovach,David P. Lee,Samuel G. Mann,Steven P. Marso,Fadi Youssef Matar,E. M. Mazzaferri,Farrel Mandelsohn,Issam Moussa,Timothy N Murphy,Sandeep Nathan,Brian H. Negus,Sahil A. Parikh,Manesh R. Patel,Kirikumar Patel,Basil M. Paulus,George Petrossian,Alex Fritz Powell,Jacek J. Preibisz,Florian Rader,Otelio S. Randall,Mahmood K. Razavi,J. Reilly,Jonathan S. Reiner,Michael Ring,Mark Robbins,Kevin L. Rogers,N. Ruggiero,Renato M. Santos,William Wyatt Little,John Schindler,T. Scott,Thomas M. Shimshak,Mehdi H. Shishehbor,Mitchell Silver,Jasvindar Singh,K. Singh,David P. Slovut,Rick G Stoufer,Paul Teirsten,Thomas M. Todoran,George W. Vetrovec,Ron Waksman,Yale Wang,Sergio Waxman,R. C. Wilkins,Khaled M. Ziada,Frank J. Zidar +106 more
TL;DR: The SYMPLICITY HTN-3 trial showed the safety but not efficacy of the Symplicity system at 6 months follow-up in patients with treatment-resistant hypertension, and long-term blood pressure changes in renal artery denervation and sham control groups are reported.
Journal ArticleDOI
Correlation between noninvasive and endovascular Doppler in patients with atherosclerotic renal artery stenosis: a pilot study.
TL;DR: Patients with atherosclerotic renal artery stenosis have preserved vasomotor response to papaverine, as well as marked increases in renal flow and resistive index following successful renal artery stenting, and a correlation was found between the noninvasive and endovascular measures diastolic/systolic ratio.